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Abstract
Background: Ovarian sex hormones (OSHs) are implicated in cardiovascular function. It has been shown that OSHs
play an important role in the long term regulation of cardiac sarcoplasmic reticulum (SR) function and contractility,
although early effects of OSHs deprivation on myocardial contractility have not yet been determined. This study
evaluated the early and late effects of OSHs deficiency on left ventricular contractility in rats after ovariectomy.
Methods: Young female Wistar rats were divided into 3 groups (n = 9-15): sham operated (Sham), ovariectomized
(Ovx) and Ovx treated with estradiol (1 mg/kg, i.m., once a week) (Ovx+E2). After 7, 15, 30 and 60 days post Ovx,
left ventricle papillary muscle was mounted for isometric tension recordings. The inotropic response to Ca2+ (0.62
to 3.75 mM) and isoproterenol (Iso 10-8 to 10-2 M) and contractility changes in response to rate changes (0.25 to 3
Hz) were assessed. Protein expression of SR Ca2+-ATPase (SERCA2a) and phospholamban (PLB) in the heart was
also examined.
Results: The positive inotropic response to Ca2+ and Iso at 7, 15, and 30 days after Ovx was preserved. However,
at 60 days, the Ovx group had decreased myocardial contractility which was subsequently restored with E2
replacement. The reduction in SERCA2a and increase in PLB expression observed at 60 days after Ovx were
restored with E2 replacement.
Conclusion: This study demonstrated that myocardial contractility and expression of key Ca2+ handling proteins
were preserved in the early phase and reduced at long-term during OSHs deprivation.
Background
Cardiovascular disease is a major contributor to morbid-
ity and mortality among post-menopausal women in the
western world [1]. Interestingly, pre-menopausal women
have a reduced risk of mortality from cardiovascular dis-
ease while post-menopausal women have a similar or
even increased risk for cardiovascular disease as com-
pared to men [2]. It has been suggested that ovarian sex
hormones (OSHs) have a protective effect on the cardio-
vascular system [2,3]. However, the effects of estrogen
replacement therapy on the cardiovascular risk only
account for about 50% of the reduction seen in cardio-
vascular disease suggesting that there must be additional
mechanisms whereby estrogen exerts its cardioprotective
effects [4]. Though observational and experimental stu-
dies have suggested that ovarian sex hormones (OSHs)
replacement therapy may be cardioprotective [5,6], large
trials utilizing oral conjugated estrogen and medroxy-
progesterone acetate did not confirm these findings [7].
In the last few years, the main ovarian hormone,
estrogen (E2), has received special attention for its pro-
tective effects against atherosclerosis [8,9]. Several stu-
dies have also indicated that E2 directly protective of
cardiac muscle contractility [10,11]. However, though
studies have indicated that OSHs therapy restore con-
tractile performance in post-menopausal women
[12-14], short-term of cardiac effects of ovariectomy and
E2 replacement have not been demonstrated.
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tioning and proteomic profiles in ventricular myocytes
are directly regulated by E2 [15-18]. However, those stu-
dies only investigated cardiac performance and proteins
involved in Ca
2+ homeostasis at 4 to 10 weeks after
OSHs deprivation leaving short-term effects of OSHs
deprivation on myocardial contractility poorly under-
stood. Thus, our aim was to study the inotropic
response of left ventricular papillary muscles short and
long-term (7, 15, 30 and 60 days) after ovariectomy in
young female rats. We also investigated the expression
of cardiac regulatory proteins sarcoplasmic reticulum
(SR) Ca
2+-ATPase (SERCA2a), phospholamban (PLB)
and sodium-calcium exchanger (NCX) at 7, 15, 30 and
60 days after Ovx. We studied the expression of these
proteins primarily due the fact that PLB regulates the
Ca
2+-affinity of SERCA2a, facilitating calcium uptake
into the SR and muscle relaxation, which is considered
an important intracellular mechanism involved in myo-
cardial contractility [19,20].
Methods
Animal care
T h ec a r ea n du s eo ft h el a b o r a t o r ya n i m a l sw e r ei n
accordance with National Institutes of Health (NIH)
guidelines and were approved by the local animal ethics
committee. All rats had free access to water and were
fed with food ad libitum.
Experimental groups, surgical procedures and E2
replacement. Eight-week-old female Wistar rats weight-
ing 185g approximately were randomly divided into two
groups. One group underwent bilateral ovariectomy
(Ovx) as described previously [21]. Briefly, a dorsal mid-
line skin incision was made under anesthesia caudal to
the posterior border of the ribs. The posterior abdom-
inal muscle wall was bluntly dissected, the abdominal
cavity was opened and the ovary was gently exteriorized
and removed. The uterine horn was returned into the
abdomen. The skin incision was closed with sterile
nylon sutures, and the process was repeated on the
other side. At 1 week after Ovx, a subgroup of the ovar-
iectomized rats (Ovx+E2) started treatment with estra-
diol valerate (E2) 1 mg/Kg injected, i.m., once a week
for 8 weeks. The second group underwent a sham
operation and served as normal controls (sham). Left
ventricle papillary muscle contractility was studied at 7,
15, 30 and 60 days after surgery. E2 replacement was
carried out only in the 60 day ovariectomized subgroup
because it was the only group that showed a reduction
in myocardial contractility. At the time of sacrifice, ade-
quacy of the ovariectomy was determined grossly by the
absence of ovarian tissue and marked atrophy of the
uterus [16]. We also determined the weight of the entire
animal, as well as the weight of the left and right ventri-
cles and the uterus.
Isometric tension and myocardial contractility
Rats received 500 units of heparin intraperitoneal (i.p.)
and then were anesthetized 10 minutes later with 45
mg/kg sodium pentobarbital, i.p., (Cristália, SP, Brazil).
Hearts were rapidly removed and perfused through the
aortic stump and the left ventricle papillary muscles
were dissected. Muscle preparations were mounted for
isometric tension recording and maintained in a 20 mL
glass-bath containing Krebs-Henseleit solution (in mM:
NaCl 118, KCl 4.7, CaCl2 1.25, KH2PO4 1.2, MgSO4 1.2,
NaHCO3 23 and glucose 11) at 30°C and pH = 7.4,
which was continuously aerated with 95% O2 and 5%
CO2. Resting tension was adjusted to produce maximal
contractile force (Lmax). The twitch contraction rate
was controlled by isolated rectangular pulses (10 to 15
V, 12 ms duration) through a pair of platinum electro-
des. The standard stimulation rate was 0.5 Hz (steady-
state). Isometric force development was measured with
an isometric force transducer (TSD105A, Biopac) and
normalized to muscle weight (g/g). Recording started
after 60 minutes to permit the muscle to adapt to the
new environmental conditions. Myocardial contractility
was tested by the following protocol. First, we measured
the inotropic response to changes in extracellular cal-
cium concentration (Ca
2+, 0.62 to 3.75 mM). Next, the
positive inotropic response, produced by increasing iso-
proterenol concentrations added to the bath (10
-8 -1 0
-2
M), was analyzed. Finally, we evaluated the isometric
force development relationship at stimulation rates of
0.25 to 3.0 Hz. At the end of the experiment, the papil-
lary muscle was removed and weighed for force normal-
ization (g/g).
Serum estrogen level
Blood samples were collected in tubes with anticoagu-
lant from group at 60 days after surgery. Blood samples
were centrifuged at 1,500 g for 15 min at 4°C. The
resulting serum was kept at -80°C until used to deter-
mine estrogen levels. The E2 levels in the serum were
measured using ELISA technique according to the man-
ufacturer’s instruction.
Western blot analysis of SERCA2a, NCX and PLB
Proteins from homogenized hearts (100 μg) were sepa-
r a t e db y7 . 5 %( S E R C A 2 aa n dN C X )o r1 5 %( P L B )S D S -
PAGE. Proteins were transferred to nitrocellulose mem-
branes for SERCA2a and NCX and polyvinyl difluoride
membranes for PLB and were incubated with mouse
monoclonal antibodies for SERCA2a (1:1000, Affinity
BioReagents, CO, USA), NCX (1:200, Abcam
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eagents, CO, USA). After washing, membranes were
incubated with anti-mouse (1:5000, StressGen, Victoria,
Canada) immunoglobulin antibody conjugated to horse-
radish peroxidase. After thorough washing, immuno-
complexes were detected using an enhanced horseradish
peroxidase/luminal chemiluminescence system (ECL
Plus, Amersham International, Little Chalfont, UK) and
film (Hyperfilm ECL International). Signals on the
immunoblot were quantified with the National Institutes
of Health Image V1.56 computer program. The same
membrane was used to determine GAPDH expression
using a mouse monoclonal antibody (1:5000, Abcam
Cambridge, MA, USA).
Statistical analysis
All values are expressed as mean ± SEM. Differences
among groups were analyzed using the two way
A N O V At e s tf o l l o w e db yt h eT u k e yp o s th o ct e s tf o r
multiple comparisons. A p value < 0.05 was considered
statistically significant. For protein expression, data are
expressed as the ratio between protein and GAPDH
signals.
Drugs and chemicals
All chemicals, unless specified in the text, were pur-
chased from Sigma Chemical (St. Louis, MO).
Results
Rat weights
The body weights of the ovariectomized rats were signif-
icantly greater than those of sham controls at 15, 30 and
60 days (Table 1). E2 treatment prevented weight gain at
60 days after ovariectomy and also restored the estrogen
levels at the same levels as the control animals (Sham:
127 ± 11.5 pmol/L, Ovx : 50.4 ± 11.4* pmol/L and Ovx
+ E2: 142.2 ± 31 pmol/L; p < 0.05). Ovariectomy and E2
replacement did not alter the left or right ventricle
weight to body weight ratio. Starting at 7 days, the defi-
ciency of OSH induced a significant decrease in uterine
weight compared with that of sham controls.
Restoration of uterine mass was observed in the E2 trea-
ted group (Table 1).
Isometric contractility response to calcium
It is well known increases in extracellular Ca
2+ results in
enhanced calcium influx through L-type Ca
2+ channels
triggering further Ca
2+ release from Ca
2+ stores within
the SR [22]. This in turn leads to a rise of intracellular
free Ca
2+ culminating in myofilament shortening and
cell contraction. As expected, increases in extracellular
Ca
2+ resulted in a positive inotropic response (Figure 1).
We found no significant differences in the inotropic
response to calcium at 7, 15, and 30 days among ovar-
iectomy and control groups. However, deprivation of
OSHs at 60 days induced a reduction in the inotropic
response to extracellular Ca
2+.
Force increases with increasing myocardial mass, char-
acterizing a positive correlation between theses variables.
Assuming the 60 days group is older and the papillary
muscles are heavier, we expected to find higher values
for all parameter in the 60 days groups. As the OVX
group has a contractility dysfunction, the force did not
increase as expected.
Isometric contractile response to b-adrenergic receptor
stimulation
Using a nonspecific b-adrenergic agonist, isoproterenol,
dose-response curves were assessed (Figure 2). Stimulation
of this subtype of b-adrenergic receptor in the heart by iso-
proterenol increases contractility and accelerates relaxation
by activating the adenylyl cyclase/cAMP/protein kinase
pathway [23]. As expected, isoproterenol promoted a posi-
tive inotropic effect in all groups examined. However, the
positive inotropic response was decreased in the ovariecto-
mized group at 60 days compared with sham controls.
Force-frequency relationship
The relationship between rate and isometric force
(Figure 3) is species-specific and was first described by
Bowditch in 1871. In the rat, a reverse staircase phe-
nomenon has been demonstrated, where force of
Table 1 Weight data from sham, ovariectomized (Ovx) and estrogen replacement
7 days 15 days 30 days 60 days
Sham Ovx Sham Ovx Sham Ovx Sham Ovx Ovx+E2
BW (g) 195 ± 3 201 ± 5 204 ± 3 232 ± 8* 233 ± 3 274 ± 5* 256 ± 5 310 ± 9* 251 ± 9
#
LV/BW (mg/g) 2.25 ± 0.06 2.12 ± 0.07 2.21 ± 0.07 2.07 ± 0.05 2.25 ± 0.09 2.09 ± 0.06 2.0 ± 0.03 1.9 ± 0.04 1.93 ± 0.05
RV/BW (mg/g) 0.57 ± 0.02 0.55 ± 0.02 0.52 ± 0.02 0.53 ± 0.01 0.54 ± 0.01 0.58 ± 0.04 0.48 ± 0.03 0.49 ± 0.02 0.54 ± 0.02
Uterus/BW (mg/g) 2.09 ± 0.14 0.70 ± 0.04* 2.40 ± 0.17 0.60 ± 0.05* 1.96 ± 0.07 0.47 ± 0.04* 2.60 ± 0.16 0.45 ± 0.04* 2.56 ± 0.19
#
Papillary Muscle (mg) 5.5 ± 0.46 5.6 ± 0.56 4.9 ± 0.35 6.1 ± 0.51 4.11 ± 0.36 5.0 ± 0.4 5.2 ± 0.47 5.7 ± 0.33 5.9 ± 0.5
LV - Left Ventricle, RV - Right Ventricle, BW - Body Weight. Data are expressed as mean ± SEM.
*OVx vs Sham,
# Ovx+E2 vs Ovx, p < 0.05 unpaired t-test. N = 6-15 (Ovx+E2) groups
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Figure 1 Inotropic response to calcium. Effect of increasing extracellular calcium concentration from 0.62 to 3.75 mM on force development
in isolated left ventricle papillary muscles from sham operation (Sham) and ovariectomized (Ovx) rats at 7, 15, 30 and 60 days after surgery.
Force (g/g) values are expressed as mean ± S.E.M. *different from sham (P < 0.05) using two-way ANOVA and post hoc Tukey test. Number of
animals used is indicated.
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Figure 2 Inotropic response to isoproterenol. Effect of the b-adrenergic agonist isoproterenol in increasing concentrations from 10
-8 to 10
-2
M on force development in isolated left ventricle papillary muscles from Sham operation (Sham) and ovariectomized (Ovx) rats at 7, 15, 30 and
60 days after surgery. Extracellular Ca
2+ concentration was 0.62 mM. Force (g/g) values are expressed as mean ± S.E.M. *different from sham (P <
0.05) using two-way ANOVA and post hoc Tukey test. Number of animals used is indicated.
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Page 4 of 10contraction falls as heart rate increases. It has been
demonstrated that the time to peak isometric force var-
ies directly with the duration of the active state, and
thus changes in duration are reflected in changes in the
peak force [24]. The Bowditch staircase phenomenon
was investigated by changing the stimulation rate from
0.25 to 3.0 Hz following rest periods of approximately
60 s. As expected, a decrease in rate of stimulation pro-
duced an immediate increase in peak force. This inverse
relationship was preserved in all groups, and was similar
between controls and Ovx rats at 7, 15 and 30 days but
reduced in Ovx rats at 60 days.
Effect of ovariectomy on maximum positive and negative
force derivatives
To determine whether the contractile deficit found in
the inotropic response to calcium and isoproterenol was
also observed in the activation or relaxation phase of
f o r c ed e v e l o p m e n t ,w em e a s u r e dt h ep o s i t i v ea n dn e g a -
tive rate of force development (dF/dt) (Figure 4). Posi-
tive dF/dt was reduced at 60 days after Ovx in all
inotropic interventions assayed. There were no signifi-
cant differences in negative dF/dt between Ovx and
sham groups.
Estrogen replacement therapy
As previously stated, ovariectomy-induced deficiency in
OSH resulted in a significant decrease in inotropic
response only after long-term (60 days) hormone depri-
vation. To determine if estrogen was involved in this
effect, ovariectomized rats were treated with estradiol
valerate for 8 weeks starting one week after surgery.
Estrogen replacement efficiently prevented the decrease
in the positive inotropic response to extracellular Ca
2+
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Figure 3 Inotropic response to frequence. Effect of ovariectomy on the rate-isometric force development relationship from 0.25 to 3.0 Hz in
isolated left ventricle papillary muscles from sham operation (Sham) and ovariectomized (Ovx) rats at 7, 15, 30 and 60 days after surgery. Force
(g/g) values are expressed as mean ± S.E.M. *different from sham (P < 0.05) using two-way ANOVA and post hoc Tukey test. Number of animals
used is indicated.
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Page 5 of 10(Figure 5A) and isoproterenol (Figure 5B), and also
restored the force-frequency relationship (Figure 5C).
Western blot analysis of SERCA2a, NCX and PLB
Alterations to cardiac mechanical properties and intra-
cellular calcium homeostasis are dependent on SER-
CA2a, PLB and NCX. In this study, we examined the
role of these proteins in the altered myocardial contrac-
tility seen in rats 60 days after ovariectomy. As shown
in the Figure 6A and 6B, Ovx altered SERCA2a. Ovx
reduced SERCA2a protein expression and increased PLB
protein expression in the heart. E2 administration was
effective in preventing those changes. Figure 6C demon-
strates that PLB was overexpressed by 1.6 fold compared
to the sham group. Meanwhile, NCX protein expression
remained unchanged (Figure 6D). We also evaluated
S E R C A 2 aa n dP L Bi nr a t sa t7 ,1 5a n d3 0 .S E R C A 2 a
and PLB did not differ between Sham and Ovx at 7, 15
and 30 days after ovariectomy (Figure 7)
Discussion
This study examines the effects of OSHs deprivation on
cardiac contractility in rats at both short and late-term
periods after ovariectomy. Our results demonstrated
myocardial contractility was preserved short-term. How-
ever, at long-term, deficiency in OSHs reduced cardiac
contractility which was associated with changes in
expression of key contractile proteins, SERCA2a and
PLB. The long-term ovariectomy-induced reduction in
myocardial contractility corroborates data previously
described [15-18]. The novel finding in this study is that
changes in contractility due to ovariectomy were not
evident until 60 days after hormone loss. Interestingly,
myocardial contractility, analyzed at 7, 15 and 30 days,
was preserved during basal conditions and even under
positive inotropic stimuli. Besides, at 60 days the Sham
group showed an increasing in myocardial contractility
response to calcium and Isoproterenol corroborating
data previously described [26].
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Figure 4 Lusitropic response to calcium and isoproterenol. Effect of ovariectomy on maximal and minimal rate of change in force in left
ventricle papillary muscles isolated from sham operation (Sham) and ovariectomized (Ovx) rats at 60 days. A - Maximum and minimum dF/dt in
increasing extracellular calcium concentrations from 0.62 to 3.75 mM. B- Effect of the b-adrenergic agonist isoproterenol in increasing
concentrations from 10
-8 to 10
-2 M in isolated left ventricle papillary muscles from sham operation (Sham) and ovariectomized (Ovx) rats.
Extracellular Ca
2+ concentration was 0.62 mM. Force (g/g) values are expressed as mean ± S.E.M. *different from sham (P < 0.05) using two-way
ANOVA and post hoc Tukey test. Number of animals used is indicated.
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ratio was increased at 60 days in the Ovx group by
approximately 1.6-fold and was normalized after E2
treatment. The protein expression of NCX remained
unchanged. Based on transgenic and gene-targeted
mouse model studies, alterations to the PLB to
SERCA2a ratio has been suggested to be a major regula-
tor of cardiac contractility [25,27]. In vivo studies using
transgenic mice which overexpress cardiac specific PLB
suggested that the “functional stoichiometry” of PLB/
SERCA2 is less than 1:1 in native cardiac sarcoplasmic
reticulum membranes [27]. Two-fold higher PLB protein
levels in these transgenic mice as compared to WT,
resulted in greater inhibition of Ca
2+-ATPase affinity for
Ca
2+, which was associated with decreases in contracti-
lity and Ca
2+ transport in cardiomyocytes.
This suggests that changes observed in SR protein
expression at 60 days in Ovx rats may be responsible
for the reduced contractility observed. Further, because
E2 replacement restored SR protein expression and
myocardial contractility, it is plausible that OSHs parti-
cipate in the long-term regulation of cardiac contracti-
lity. In fact, a previous study observed thyroid hormone
regulation of SR protein expression and cardiac contrac-
tility [28]. These authors also observed enhanced cardiac
PLB expression which was associated with decreased
rates of cardiac SR Ca
2+ uptake which is consistent with
increased inhibition of the cardiac SR Ca
2+ pump and
decreased contractility in hypothyroid rats.
Long-term studies demonstrated the influence of
OSHs on rat cardiac contractility [13] through
impaired left ventricular function. Impaired function
was characterized by decreases in cardiac output, peak
systolic pressure and ejection fraction at all preloads in
the hearts of rat ovariectomized before puberty. These
contractile changes were further associated with a
decrease in myosin ATPase activity. Another study
[14] demonstrated the same changes in cardiac func-
tion which were reversed by E2 replacement. Further
studies reporting changes in intracellular Ca
2+ homeos-
tasis in cardiomyocytes suggest a possible modulating
effect of OSH deficiency on the Ca
2+ responsiveness of
cardiac myofilament activation by induction of myofila-
ment Ca
2+ hypersensitivity but suppression of maxi-
mum myofibrillar ATPase activity [28,16], which may
underlie the cardiac dysfunction observed in OSHs
deficiency. These findings support our results. The reg-
ulatory role of OSHs in the calcium uptake activity of
cardiac SR was also demonstrated in 10 week ovariec-
tomized rat hearts [16]. These authors demonstrated
that estrogen and progesterone supplementation were
equally effective in preventing changes in ovariecto-
mized hearts.
In our study, 30 days after Ovx, myocardial isometric
contractility in response to extracellular Ca
2+ and b-
adrenergic agonist as well as the rate-force development
relationship were preserved. In another study, hormone
status did not affect levels of SERCA2a, PLB, ryanodine
receptor and the mRNA encoding for b1-adrenoreceptor
at 4 weeks post ovariectomy in rat [17]. Chu et al.
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Figure 5 Estrogen effects on inotropic stimulus.E f f e c to f
estrogen replacement therapy with estradiol valerate on myocardial
contractility 60 days after ovariectomy. Estrogen restores inotropic
response to extracellular calcium (A) and isoproterenol (B) as well as
the rate-isometric force development relationship (C). Force (g/g)
values are expressed as mean ± S.E.M. * Ovx n = 8 vs. Sham n = 22,
# Ovx vs. Ovx + E2 n = 8, different (P < 0.05) using two-way ANOVA
and post hoc Tukey test.
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isoproterenol-elicited increase in developed force though
the abundance of b1-adrenoreceptor was over 2-fold
higher in the Ovx group compared with Sham.
We also conducted our study at an early stage after
ovariectomy. Rat hearts were studied at 7 and 15 days
post ovariectomy. Clear evidence of OSH absence was
observed as early as 7 days after ovariectomy with a
close to 3-fold reduction in uterus weight compared to
sham animals. In addition, there was an increase in
body weight in the Ovx rats at 15 days. However, myo-
cardial contractility was preserved in these animals.
E2 receptor signaling in the cardiovascular system is a
complex process that is not completely understood. Its
effects on the vascular system have been demonstrated
in normal rats [30] and after myocardial infarction [31].
It is well recognized that E2 has genomic and non-
genomic actions. The long-term effects of estrogen are
mediated by different nuclear hormone receptors, ER a
and ER b, which are encoded by different genes and act
as ligand-dependent transcription factors [32]. To date,
a number of mechanisms have been proposed to deci-
pher the cardio protective effects of E2. E2 alters the
expression of ventricular ß1-adrenoreceptor [17,33],
intracellular calcium homeostasis related to the L-type
Ca
2+ channel [35], cardiac SR Ca
2+ uptake [16] and Ca
2
+ sensitivity of cardiac myofilaments in ovariectomized
rats [29], which are important mediators of cardiac con-
tractility. Although a cardiac transcriptional regulation
of estrogen is well described, there is little direct evi-
dence of membrane cardiac estrogen receptors. Data
reporting on the non-genomic signal transduction in
cardiomyocytes have demonstrated that 17b estradiol
has a negative inotropic effect on guinea-pig single
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Figure 6 Calcium handling protein expression. Densitometric analysis of Western blots for (A) SR Ca
2+-ATPase (SERCA2a), (B) phospholamban
(PLB), (C) SERCA2a/PLB ratio and (D) sodium - calcium exchange (NCX) in hearts from sham, Ovx and Ovx + E2 rats. * p < 0.05 by ANOVA vs.
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Page 8 of 10ventricular myocytes by inhibiting ICa and so reducing
systolic Ca
2+ [35].
Furthermore, in isolated rat ventricular cardiomyo-
cytes, it was demonstrated that E2 exerts opposite
effects on intracellular myocyte pH, which is associated
with pro-and anti-hypertrophic effects [36].
A question raised by the results presented here is
whether OSHs affects the myocardium directly or by
secondary mechanisms involving other hormones modu-
lated by E2. Also, as contractility was altered so late
after loss of OSHs, does E2 act only by genomic
mechanisms, or are compensatory mechanisms involved
in the short term? Further studies are necessary to clar-
ify these questions. Taken together, our results suggest
that changes in Ca
2+ handling due to abnormal SR func-
tion may contribute to reduced myocardial contractility
in chronically OSH-deficient rats. Further studies would
be beneficial to determine the importance of these find-
ings in humans, as there are significant species-depen-
dent differences in PLB regulation of SERCA2a [37].
Further, long-term rather than short-term estrogen sup-
pression lead to contractile dysfunction which was sub-
sequently reversed with estrogen replacement.
Conclusions
In conclusion, the most novel aspect demonstrated in
this study is the long delay in development of cardiac
dysfunction after ovariectomy in young female rats.
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